Covered recipient · General Payments record
MARK H PICO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2020–2024
$1,381.09
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $445.47 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bolton Medical Inc | $140.09 | 1 |
| Amgen Inc. | $62.24 | 4 |
| PFIZER INC. | $52.11 | 3 |
| Janssen Pharmaceuticals, Inc | $50.02 | 2 |
| Abbott Laboratories | $48.18 | 2 |
| Acerta Pharma LLC | $31.33 | 2 |
| Lilly USA, LLC | $17.89 | 1 |
| Novo Nordisk AS | $15.21 | 1 |
| Merck Sharp & Dohme Corporation | $14.66 | 1 |
| GlaxoSmithKline, LLC. | $13.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.82 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125160080 | CMS |
| Abbott Laboratories | $23.36 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125160082 | CMS |
| Amgen Inc. | $14.44 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111677005 | CMS |
| Amgen Inc. | $17.34 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117354019 | CMS |
| Amgen Inc. | $15.29 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111677007 | CMS |
| Amgen Inc. | $15.17 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111677009 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.65 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105557318 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.68 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105239075 | CMS |
| Bolton Medical Inc | $140.09 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150748960 | CMS |
| GlaxoSmithKline, LLC. | $13.74 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116435643 | CMS |
| Janssen Pharmaceuticals, Inc | $29.62 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077912773 | CMS |
| Janssen Pharmaceuticals, Inc | $20.40 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077912805 | CMS |
| Lilly USA, LLC | $17.89 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135168216 | CMS |
| Merck Sharp & Dohme LLC | $14.66 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141680903 | CMS |
| Novo Nordisk Inc | $15.21 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097437395 | CMS |
| PFIZER INC. | $19.09 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131318921 | CMS |
| PFIZER INC. | $15.25 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131839508 | CMS |
| PFIZER INC. | $17.77 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132083236 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.